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Much of the bone, cartilage and smooth muscle of the vertebrate face is derived from neural crest (NC)
cells. During craniofacial development, the anterior neural ridge (ANR) and olfactory pit (OP) signaling
centers are responsible for driving the outgrowth, survival, and differentiation of NC populated facial
prominences, primarily via FGF. While much is known about the functional importance of signaling
centers, relatively little is understood of how these signaling centers are made and maintained. In this
report we describe a dramatic craniofacial malformation in mice mutant for the zinc ﬁnger transcription
factor gene Sp8. At E14.5 they show facial prominences that are reduced in size and underdeveloped,
giving an almost faceless phenotype. At later times they show severe midline defects, excencephaly,
hyperterlorism, cleft palate, and a striking loss of many NC and paraxial mesoderm derived cranial bones.
Sp8 expression was primarily restricted to the ANR and OP regions during craniofacial development.
Analysis of an extensive series of conditional Sp8 mutants conﬁrmed the critical role of Sp8 in signaling
centers, and not directly in the NC and paraxial mesoderm cells. The NC cells of the Sp8 mutants showed
increased levels of apoptosis and decreased cell proliferation, thereby explaining the reduced sizes of the
facial prominences. Perturbed gene expression in the Sp8 mutants was examined by laser capture
microdissection coupled with microarrays, as well as in situ hybridization and immunostaining. The most
dramatic differences included striking reductions in Fgf8 and Fgf17 expression in the ANR and OP
signaling centers. We were also able to achieve genetic and pharmaceutical partial rescue of the Sp8
mutant phenotype by reducing Sonic Hedgehog (SHH) signaling. These results show that Sp8 primarily
functions to promote Fgf expression in the ANR and OP signaling centers that drive the survival,
proliferation, and differentiation of the NC and paraxial mesoderm that make the face.
& 2013 Elsevier Inc. All rights reserved.Introduction
In 1968 Wilhelm His, a Swiss embryologist, made the contro-
versial discovery that cells could migrate from the developing
neural tube and form non-neural tissues (Horstadius, 1950). These
observations identiﬁed an ectodermal origin for mesenchyme and
skeletal tissues traditionally believed to only arise from mesoderm.
We now know that these neural crest (NC) cells contribute many
components of the vertebrate face, including smooth muscle, bone,
teeth and cartilage. In time two distinct models for NC development
emerged. The ﬁrst declared that NC cells are pre-patterned, acquir-
ing their developmental properties prior to their exit from the
neuroepithelium (Noden, 1983; Artinger and Bronner-Fraser, 1992;
Hunt et al., 1998). The second argued that ongoing interactions
between the migrating NC cells and their surrounding tissues drive
differentiation and morphogenesis (Baker et al., 1997; Couly et al.,
2002; Lee et al., 2001; Tyler and Hall, 1977). We now realize that
there is a combination of initial developmental potential andll rights reserved.
Potter).continuous dynamic dialog with ﬂanking cells that together reg-
ulate NC developmental direction (Le Douarin et al., 2004; Noden
and Schneider, 2006).
During craniofacial development there is essential crosstalk
between the cephalic NC and the neuroepithelium of the developing
brain. In the chick model system it has been shown that surgical
extirpation of the early NC results in loss of Fgf8 expression in the
anterior neural ridge (ANR) of the telencephalon, a key signaling
center for both brain and NC development (Creuzet et al., 2006). FGF8
acts as a diffusible morphogenwith organizer activity in the neocortex
(Fukuchi-Shimogori and Grove, 2001; Toyoda et al., 2010). While the
NC is required to establish this telencephalon signaling center, the
resulting FGF is in turn required for proper development of the NC
(Creuzet et al., 2004). FGF8 is chemotactic for NC (Sato et al., 2011), and
promotes its survival and proliferation (Trumpp et al., 1999). The
olfactory pit (OP) is another important signaling center during
craniofacial development, and provides an additional source of FGF8
(Szabo-Rogers et al., 2009). Studies of mice with reduced FGF8
signaling further demonstrate that it is a key mediator of proper
orientation and polarity of facial primordia and subsequent frontona-
sal skeletal morphogenesis (Grifﬁn et al., 2013). Altogether, these
studies demonstrate the essential roles of FGF8 during craniofacial
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survival, proliferation and differentiation of NC cells, we understand
relatively little of how these signaling centers are made and
maintained.
We previously reported the generation of a transgene insertional
mutant mouse, named legless, that showed shortened hindlimbs,
randomized laterality, and craniofacial malformations (McNeish
et al., 1988). The transgene insertion resulted in a large deletion,
encompassing many genes. We cloned the Lrd dynein gene from the
deleted region, showed that it is expressed in the node during
development, and is required for nodal cilia motility, thereby begin-
ning to explain the randomized laterality (Supp et al., 1997, 1999).
However, mice with a targeted mutation in Lrd did not show limb or
craniofacial defects, suggesting that another altered gene was respon-
sible (Supp et al., 1999). We subsequently showed that the transgene
insertion is near, but does not delete or disrupt, the Sp8 zinc ﬁnger
transcription factor gene, creating a hypomorph allele (Bell et al.,
2003). Targeted null mutation of Sp8 gives a much more severe limb
phenoytpe, with extreme truncation of both forelimbs and hindlimbs,
as well as an absent tail (Bell et al., 2003). During limb development
the apical ectodermal ridge (AER) is a signaling center that produces
FGF8 and drives limb outgrowth. In the Sp8 mutants the AER fails to
mature and Fgf8 expression is lost, thereby explaining the truncated
limbs (Bell et al., 2003).
In addition to limb defects the Sp8 mutant mice show dramatic
craniofacial malformations. In this report we describe the develop-
mental time course of the Sp8 mutant, showing that at E14.5 the
reduced facial rudiments are underdeveloped, giving an almost
faceless phenotype. We also better deﬁne the expression pattern of
Sp8, ﬁnding elevated levels in the anterior neural ridge (ANR) as well
as the olfactory placodes and the epidermal ectoderm during cranio-
facial development. Further, to determine key functional domains of
Sp8 expression we generated an extensive series of conditional Cre-
driven compartment-speciﬁc mutants. To identify possible down-
stream targets we globally examined altered gene expression in the
Sp8 mutants in multiple facial rudiments using laser capture micro-
dissection (LCM) and microarrays. The results indicated disrupted FGF
signaling as well as altered apoptosis and cell proliferation. Perturbed
pathways were further studied by in situ hybridizations, and function-
ally validated by genetic interaction and pharmaceutical rescue. The
results show that in the developing face, as in the limb, Sp8 is required
for the proper function of key signaling centers.Materials and methods
Mice
The ﬂoxed-Sp8 (Bell et al., 2003), FoxG1-Cre (Hebert and McConnell,
2000), Wnt1-Cre (Danielian et al., 1998), Mesp1-Cre (Saga et al., 1999),
Pax3-Cre (Engleka et al., 2005) R26R-GFP, and BAT-gal (Harfe et al.,
2004; Maretto et al., 2003) mice were previously described. SHH-
CreGfp knock-in transgenic mice (Harfe et al., 2004) were used for
genetic rescue experiments. Experiments were carried out on a mixed
genetic background. All mice used in this study were housed in the
Cincinnati Children's Animal Care Facility according to NIH and
institutional guidelines.
Immunoﬂuorescence, histology, and skeletal preparations
Immunoﬂuorescence was performed as previously described
(Olsson et al., 1997). Primary antibodies included goat anti-SP8
(1:8000, Santa Cruz Biotechnology), rabbit anti-GFP conjugated to
Alexa488 (1:500, Invitrogen), goat anti-GFP (1:5000, Abcam),
rabbit anti-SHH (1:500, Santa Cruz Biotechnology), rabbit anti-
cleaved caspase 3 (1:200, Cell Signaling Technology), and rabbitanti-phosphohistone H3 (1:500, Upstate Cell Signaling Solutions).
Secondary antibodies included donkey anti-rabbit or donkey
anti-goat conjugated antibodies conjugated to either Alexa555 or
Alexa488 (1:200, Invitrogen). The processing and histological stain-
ing of embryonic tissue was performed as previously described
(Little et al., 2007). Skeletal Staining using Alizarin red and Alcian
blue was performed as previously described (Kuczuk and Scott,
1984). Inner Canthal Distance was measured using Leica LAS v3.8
imaging software. The student's two-tailed t-test was used to
determine differences between paired groups. A p-value of less
than 0.05 was considered signiﬁcant.
Quantiﬁcation of cell death and cell proliferation
Cells undergoing apoptosis were labeled using rabbit anti-cleaved
caspase 3 (1:200, Cell Signaling Technology) and cells undergoing
proliferation were labeled using rabbit anti-phosphohistone H3
(1:500, Upstate Cell Signaling Solutions). NC cells were labeled by
Wnt1-Cre driving the expression of the Rosa26-ﬂox-stop-ﬂox-GFP
reporter. Neuroepithelium and OP epithelium were determined by
cell morphology and location within the section. E8.5, E9.5, and E10.5
embryos were harvested, ﬁxed overnight in 4% PFA at 4 1C, embedded
in OCT, and cryosectioned at 10 μm. Fluorescent images of the cranial
region were taken at 5 , 10 , or 20 magniﬁcation. Comparable
WT and Sp8 mutant sections were used during quantiﬁcation,
approximately ﬁve sections per embryo were analyzed (Table S1).
The cells of interest undergoing either apoptosis or proliferation were
manually scored using Image J software. The student's two-tailed t-test
was used to determine differences between paired groups. A p-value
of less than 0.05 was considered signiﬁcant.
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as previously
described (Bell et al., 2003; Little et al., 2007). Mouse cDNA probes
were kindly provided by Sheila Bell (Fgf8 and Erm) (Bell et al., 2003)
and Rulang Jiang and Yu Lan (Dlx5) (Baek et al., 2011). The Fgf17
riboprobe was made from pCR4-TOPO vector clone ID number
8733782 using forward primer CTGTATGAACAAGAGGGGCAA and
reverse primer GAAATTAATACGACTCACTATAGGCTGCCTCTGGCCT-
CAAACCT (with T7 RNA Polymerase binding site). The Sprouty1
riboprobe was made from liver genomic DNA using forward primer
GAGATAATACGACTCACTATAAAGCCATCAGAGGCAGCAAT (with T7 RNA
Polymerase binding site) and reverse primer GAGAATTTAGGTG
ACACTATAGGTGGGGTCCTCTTTCAAGG (with SP6 RNA Polymerase
binding site).
Western blotting
We manually dissected the middle to anterior facial structures
including the ANR from E9.5 embryos. The western blotting was
performed as previously described (Chang et al., 2012). Primary
antibodies used were GLI3 (1:1000, R&D), β-Actin (1:10,000, Abcam),
and α-Tubulin (1:10,000, Abcam). Secondary antibodies used were
Anti-Goat-HRP conjugated (1:5000, Santa Cruz Biotechnology) and
Anti-Mouse-HRP (1:5000, Bio-Rad). The relative densities of western
blots were calculated using Image J software. The student's two-tailed
t-test was used to determine differences between paired groups. A p-
value of less than 0.05 was considered signiﬁcant.
RNA puriﬁcation and Q-PCR analysis
We manually dissected the cranial neural folds from E8.5
embryos, the middle to anterior facial structures including the
ANR from E9.5 embryos, and the OP, LNP and MNP from E10.5.
Total RNA was puriﬁed using the ZR RNA Microprep Kit (Zymo
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time Q-PCR using the SYBR Green PCR Master Mix (Bio-Rad) and
the CFX96 Real Time thermocycler (Bio-Rad). Speciﬁc primer pairs
were designed to detect target gene expression levels. Gene
expression levels were normalized to β-actin or Tubbβ5.
Primers used for Q-PCR:Gene Forward
strandReverse
strandAmplicon size
(bp)Fgf8 TTGGA-
AGCA-
GAGTC-
CGAGTTATACG-
CAGTCCTTG-
CCTTTG108Fgf17 TCGTG-
GAGA-
CAGA-
TACATT-
CGGCTTGCCCC-
TCTTGTTCA-
TA87Gli1 GCCTT-
GAAAA-
CCTCAA-
GACGATGGCTTCT-
CATTG-
GAGTGG144Gli2 ACCAT-
GCCTAC-
CCAACT-
CAGCCTCAGCCT-
CAGTCTT-
GACC145Gli3 GAGCA-
GAAAC-
CGTTCA-
AAGCTGGGTTTTC-
AGGTTTTC-
GAG131Ptch1 CCACG-
GTTGCT-
GTA-
GATTGTGCCGCAGTT-
CTTTTGAAT-
GT122Shh CCAAT-
TACAAC-
CCCGA-
CATCGGCCAAGG-
CATT-
TAACTTGT98Smo TCAAT-
GCGTG-
TTTCTT-
CGTGACAGGGTCT-
CACTG-
GAGGTG129Smo TCGGG-
CAAGA-
CATCC-
TATTTCTCCATC-
TACCTGAGC-
CACA91β-Actin AAT-
GAGGC-
TGGTG-
ATAAGT-
GGAAGTT-
CAGTGTGCT-
GGGAGTC99Tubbβ5 GCAGTT-
GGA-
GAAAG-
CTGAGGGGAAGAG-
GATTTCGGA-
GAGG97Laser capture microdissection, microarray hybridization, and data
analysis
Tissues were embedded, sectioned, and microdissected as
previously described (Brunskill et al., 2008). RNA puriﬁcation,
target ampliﬁcation, and microarray data analysis was performedas previously described (Brunskill et al., 2011). Microarray data is
available on the FACEBASE.ORG public data Website, listed as
Sp8/ E10 LNE, Sp8 / E10 LNE2, Sp8 / E10 LNE3, Sp8 /
E10 MNE, Sp8 / E10 MNE2, Sp8 / E10 MNE3, Sp8 / E10 OP,
Sp8/ E10 OP2, Sp8 / E10 OP3, and corresponding wild type
samples.Embryonic exposure to cyclopamine
Cyclopamine (Selleck, S1146) was dissolved in 0.1 M sodium
citrate/phosphate pH3 containing 30% 2-hydropropyl-b-
cyclodextrin (HPBCD) (Sigma 332607) as previously described
(Lipinski et al., 2008, 2010). Cyclopamine was administered using
Alzet Micro-osmotic Pump model 2001D (8 ml/h for 1 day) (Durect
Corp, Cupertino, CA). The micro-osmotic pumps were implanted
subcutaneously under the back skin of the pregnant dam at E8.25
and were removed at E10.5. Pumps were ﬁlled with 2 mg cyclo-
pamine/100 ml 30% HPBCD to achieve approximate 160 mg/kg/day
(one pump implanted) or 260 mg/kg/day (two pumps implanted)
cyclopamine release rates (Lipinski et al., 2008, 2010). In separate
experiments cyclopamine was administered by single IP injection
at 25 mg/kg or 50 mg/kg dissolved in 45% HPBCD (Sigma, H5784).
The injected volume was approximately 150 ml and administered
every 12 h from E7.5 to E10.0 (Lipinski et al., 2008).Results
Sp8 is required for normal craniofacial development
Sp8 / mutant mice showed dramatic craniofacial malforma-
tions (Fig. 1). At E14.5 they displayed hypertelorism, severe mid-
line defects and an absence of many normal facial structures
(Fig. 1A and B). The tongue and mandible appeared normal, but
the medial nasal prominences (MNP) remained severely under-
developed and were not merged with other facial elements. The
lateral nasal prominences (LNP) and maxillary prominences (MXP)
were more normal in size, but also failed to undergo normal
development, giving the face a very primitive appearance, resem-
bling that of a much younger embryo. The MXP ordinarily gives
rise to the upper jaw, sides of the face, and secondary palate, while
the LNP produces the lateral walls of the nose, and the MNP gives
rise to more medial structures (Helms et al., 2005). To better
deﬁne the developmental progression of Sp8 mutant malforma-
tions we examined embryos from E8.5 to birth. The earliest gross
evidence of craniofacial defect was seen at E9.5, with failure of
anterior neuropore closure (data not shown). At E10.5, E11.5 and
E12.5 all prominences were formed in mutants, but the MNP and
LNP were dramatically reduced in size and underdeveloped
(Fig. 1G–R).
Skeletal and cartilage preparations of Sp8 mutants at E18.5
showed loss or malformation of multiple NC-derived bones. The
palate, maxilla, premaxillary and frontal bones, all NC derivatives,
were absent or reduced in size and misshapen. Interestingly, there
was also a reduction of the paraxial mesoderm derived parietal,
interparietal, and supraoccipital bones (Fig. 1C–F). The result was a
large hole in the skull between the residual frontal and parietal
bones, where the excencephalic brain was exposed.
We also investigated palate development in the Sp8 mutants.
The palatal shelves normally develop vertically aligned next to the
tongue at E13.5, and then elevate and fuse to form the palate by
E16.5 (Bush and Jiang, 2012). Histological analysis revealed that
Sp8 mutant palatal shelves were reduced in size, prematurely
elevated and failed to fuse along the midline even at E16.5,
resulting in a cleft palate (Fig. S1).
Fig. 1. Sp8 is required for proper nasal prominence morphogenesis. (A and B) E14.5 Sp8 mutant embryos (B) display severe failure of midline fusion and a loss of many facial
structures compared to WT (A). (C–F) Wild type (C and E) and Sp8 mutant (D and F) skeletal preparations show loss of many NC derived bones in mutants, including the
maxilla, palate, and frontal bone. Paraxial mesoderm-derived parietal and interparietal bones are also absent in Sp8 mutants. Dotted circle in panel F indicates a hole in the
skull where the brain is exposed in the Sp8 mutant. (G–R) Facial prominences were digitally pseudo-colored red (maxillary prominence), blue (lateral nasal prominence),
green (medial nasal prominence), and purple (frontonasal region) in E10.5, E11.5, and E12.5 WT (G, I, K, M, O, and Q) and Sp8mutants (H, J, L, N, P, and R). Mutant lateral and
medial nasal prominences are reduced in size and dysmorphic in shape. Exoccipital, EO; Frontal, FR; Interparietal, IP; Lateral Nasal Prominence, LNP; Mandible, MD; Maxilla,
MX; Medial Nasal Prominence, MNP; Nasal, NS; Neuroepithelium, NE; Parietal, PR; Premaxilla, PMX; Supraoccipital, SO; Tongue, T.
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Although Sp8 expression has been previously examined (Bell
et al., 2003; Kawakami et al., 2004; Sahara et al., 2007; Waclaw
et al., 2006), it has not been well deﬁned during early craniofacial
development. Immunostain analysis at E8.5 showed that the Sp8
gene was expressed in the neuroectoderm and epidermal ectoderm,
with particularly strong expression in the critical ANR signaling
center (Helms et al., 2005) (Fig. 2A and C; Fig. S2). Of interest, Sp8
expression was not detected in the NC or paraxial mesoderm, which
together make up the facial mesenchyme. Similar to the E8.5 time
point, at E9.5 Sp8 showed robust expression in the ANR, and also in
the hindbrain neuroepithelium (Fig. 2B and D). At E10.5 Sp8 was
expressed in the OP epithelium, facial epidermal ectoderm, and
robustly in the midline of the telencephalon (Fig. 2E). Similar to the
ANR, the OP epithelium is a signaling center promoting survival and
patterning of the underlying NC and mesoderm derived mesench-
yme (Kawauchi et al., 2005; Szabo-Rogers et al., 2009). These results
show that Sp8 is expressed in signaling centers that drive craniofacial
development, and not detectably in the NC and paraxial mesoderm
cells that directly contribute to the face. This is similar to what we
previously observed in the developing limb, where Sp8 is expressed
in the AER signaling center (Bell et al., 2003), but not in the
mesenchyme that makes the muscles and bones of the limbs.
Conditional deletion of Sp8 reveals critical roles in signaling centers
that ﬂank facial mesenchyme
To better deﬁne the critical domains of Sp8 expression during
craniofacial development we made mice with compartment-speci-
ﬁc Sp8 deletion. We used a Cre mediated conditional knock-out
strategy to inactivate Sp8 expression in the NC, paraxial mesoderm,
neuroepithelium, and epidermal ectoderm. To begin, we better
characterized the expression patterns of the Wnt1-Cre, Pax3-Cre,Mesp1-Cre and FoxG1-Cre strains of mice by crossing with a ﬂoxed-
stop-Rosa26-GFP reporter mouse. Although each transgenic Cre line
was previously described (Danielian et al., 1998; Engleka et al.,
2005; Hebert and McConnell, 2000; Saga et al., 1999), we were
interested in deﬁning precise spatiotemporal expression domains
during craniofacial development. The results showed Pax3-Cre
expression at E8.5 in the NC, paraxial mesoderm, hindbrain neu-
roepithelium, and in the anterior junction of the neuroepithelium
and epidermal ectoderm at the tips of the neural folds (Fig. S3A). At
E9.5 Pax3-Cre expression continued in the ANR, as well as more
caudal neuroepithelium (Fig. S3E). At E10.5 Pax3-Cre was expressed
in both the OP epithelium and underlying facial mesenchyme,
consisting of NC and paraxial mesoderm (Fig. S3I). Importantly,
Pax3-Cre expression overlapped Sp8 expression in the E8.5 ANR and
in the E10.5 OP epithelial signaling centers. Wnt1-Cre showed
expression in the mid and hindbrain neuroepithelium, and NC,
but not in the ANR or OP (Fig. S3B, F, and J). FoxG1-Cre was
expressed throughout the neuroepithelium and epidermal ecto-
derm (Fig. S3C,G, and K). At E8.5 however, expression appeared
weak, with mosaic reporter expression (Fig. S3C). Later, at E10.5,
FoxG1-Cre drove robust reporter expression in forebrain neuroe-
pithelium and the OP epithelium (Fig. S3K). Mesp1-Cre was
expressed in the paraxial mesoderm (Fig. S3D,H, and L). See Table
S2A for a summary of all transgenic Cre domains of expression.
We then used each Cre strain in combination with a ﬂoxed Sp8
allele to create tissue-speciﬁc conditional mutants. The Wnt1-Cre,
driving Sp8 deletion in the NC, gave no detectable craniofacial
phenotype (Fig. 3M, P, S, and V). This was perhaps not surprising,
since there was no Sp8 expression observed in NC. Nevertheless, it
conﬁrmed that there was no functionally important low-level NC
expression for Sp8. For nine of ten Mesp1-Cre conditional Sp8
mutants, with paraxial mesoderm speciﬁc deletion, there were no
craniofacial defects, while one mutant showed a partial facial
midline cleft (Fig. 3N, Q, T, and W). Consistent with the expression
Fig. 2. SP8 is made in the anterior neural ridge and olfactory pit signaling centers. (A and C) Immunoﬂuorescence for SP8 on transverse sections of E8.5 embryos at 9 somites
showed high SP8 levels in the hindbrain, anterior neural ridge (arrows), and epidermal ectoderm. (B andD) Sagittal sections at E9.5 revealed SP8 localization in the anterior
neural ridge (arrow) and hindbrain. (E) Coronal section at E10.5 showed robust SP8 localization in the olfactory pit epithelium signaling center (arrows) and medial
telencephalon (arrowhead). First Branchial Arch, 1BA; Foregut, FG; Forebrain, FB; Hindbrain, HB; Lateral Nasal Prominence, LNP; Medial Nasal Prominence, MNP; Midbrain,
MB; Olfactory Pit, OP.
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directly in the NC and paraxial mesoderm cells that make the face.
The Pax3-Cre conditional mutants showed the most severe
phenotypes, closely resembling the Sp8 null mutants, with excen-
cephaly, an absence of frontal and parietal bones, and a dramatic
midline cleft (n¼5, Fig. 3A, D, G, and J). There was, however,
variable expressivity. The moderate phenotype Pax3-Cre condi-
tional mutants displayed cleft lip and palate, midline defects, and a
truncation of anterior facial structures (n¼7, Fig. 3B, C, E, F, H, I ,K,
and L). In addition, ﬁve Pax3-Cre conditional mutants did not show
a detectable craniofacial phenotype.The FoxG1-Cre conditional mutants also gave variable cranio-
facial malformations, although none as striking as the most severe
Pax3-Cre conditional mutants. The moderate FoxG1-Cre mutants
displayed cleft lip and/or palate, failure of facial midline fusion
(n¼13), and a truncation of anterior facial structures (n¼13,
Fig. 3O, R, U, and X). See Table S2B for a summary of transgenic
Cre phenotypes observed.
Taken together these results indicate that Sp8 expression is
critically important in the neuroepithelium and the epidermal
ectoderm, including the OP, which ﬂank the NC. It is interesting to
note that the most severe phenotypes were observed with Pax3-
Fig. 3. Conditional Inactivation of Sp8 expression reveals important roles of Sp8 in Pax3-Cre and FoxG1-Cre expressing cells. Transgenic Cre lines selectively removed Sp8 expression in
speciﬁc tissue compartments when combined with one ﬂoxed and one null Sp8 allele. Whole mount and skeletal preparations were performed. (A–L) Pax3-Cre conditional mutants
displayed variable phenotypes. Embryos with severe malformations including excencephaly (black arrowhead), failure of facial prominence fusion along the midline (arrow),
truncation of the anterior snout structures (white arrowhead), and an absence of many cranial bones closely resembled the Sp8 null mutant (n¼4, A, D, G, and J). The moderate
phenotypes displayed cleft lip and palate, failure of facial prominence fusion along the midline (arrows), and a truncation of anterior structures (B, C, E, F, H, I, K, and L). (O, R, U, and X)
The FoxG1-Cre conditional mutants displayed malformations of the telencephalon, cleft lip (arrow), and a truncation of anterior facial structures (arrowhead). (M, N, P, Q, S, T, V, andW)
Neither theWnt1-Cre (M, P, S, and V) nor the Mesp1-Cre (N, Q, T, andW) conditional mutants displayed craniofacial phenotypes with the exception of oneMesp1-Cre mutant displaying
a mild midline defect (not shown). Exoccipital, EO; Frontal, FR; Interparietal, IP; Mandible, MD; Maxilla, MX; Nasal, NS; Parietal, PR; Premaxilla, PMX; Supraoccipital, SO.
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Fig. 4. Increased apoptosis and reduced proliferation in SP8 / facial mesenchyme.
(A) Immunoﬂuorescence for cleaved caspase-3 was used to label cells undergoing
apoptosis. Wnt1-Cre activation of R26R-GFP labeled the neural crest. Apoptosis was
quantiﬁed in various compartments of E8.5, E9.5, and E10.5 Sp8 / and WT
embryos. Results showed a signiﬁcant increase in apoptosis in the anterior
neuroepithelium at E8.5. The neural crest underwent elevated apoptosis at E9.5
as did the medial nasal prominence, lateral nasal prominence, and olfactory pit at
E10.5. (B) Immunoﬂuorescence for phospho histone H3 was used to label cells
undergoing proliferation. The neural crest was labeled by Wnt1-Cre activation of
R26R-GFP. Proliferation was quantiﬁed in various compartments of E8.5, E9.5, and
E10.5 of Sp8/ and WT embryos. Results showed a signiﬁcant decrease in the
neural crest at E9.5 as well as in the lateral nasal prominence and olfactory pit at
E10.5. Anterior Neuroepithelium, AN; Lateral Nasal Prominence, LNP; Medial Nasal
Prominence, MNP; Neural Crest Cells, NCC; Olfactory Pit, OP, po0.05(n), po0.01
(nn), po0.001(nnn).
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although in more restricted domains of the neuroepithelium.
Laser capture microdissection/microarray analysis of Sp8 mutants
To globally deﬁne the altered gene expression state of the Sp8 /
mutants we used LCM coupled with microarrays. We examined E10.5
wild type and mutant embryos using LCM to isolate three major
compartments of the developing face, the LNP, MNP, and OP
epithelium (Fig. S4G–J). Affymetrix mouse Gene 1.0 ST arrays were
used for gene expression proﬁling. While large numbers of differen-
tially expressed genes were found (Tables S3–S5), three differences
particularly stood out. The ﬁrst was a signiﬁcant down-regulation of
Fgf17 in the mutant OP epithelium. As discussed previously, FGFs are
known to be key regulators of craniofacial development, and the
tissue speciﬁc targeting results suggested that Sp8 expression in the
olfactory epithelium is important for proper craniofacial develop-
ment. The microarray data also strongly suggested increased levels of
apoptosis in mutants, with both the LNP and the MNP showing about
30 genes involved in the regulation of cell death showing elevated
expression in mutants. Finally, gene ontology analysis of the array
data showed a dramatic cell proliferation signature. In the mutant
LNE there were 43 cell cycle process genes with elevated expression,
including four (Msh2, Men1, Ppm1q and Ilk) involved in cell cycle
arrest. Similarly, the mutant MNP showed upregulation of 71 genes
involved in the cell cycle, again with four (Msh2, Men1, Ppm1q and
Sesn1) involved in cell cycle arrest.
Sp8 / neural crest show increased apoptosis and reduced
proliferation
Several results suggested an increase in apoptosis and/or
decrease in cell proliferation in the Sp8 mutants, including the
reduced sizes of the facial prominences during development, the
striking absence of many NC and mesoderm derived cranial bones
at birth, and the LCM/microarray results. We therefore monitored
apoptosis by quantifying the number of cleaved caspase-3 positive
cells in wild type and Sp8 / mutant embryos. We identiﬁed NC
cells by labeling with Wnt1-Cre activation of ﬂoxed-stop-Rosa26-
GFP. At E8.5 there was a striking 3-fold increase in apoptosis in the
anterior neuroepithelium of the cranial neural folds, which
includes the ANR, but no elevated apoptosis in the NC (Fig. 4A
and Fig. S4A and B). This extends previous results showing
elevated neuroepithelium apoptosis in Sp8 / mutants at later
developmental time points (Waclaw et al., 2006; Zembrzycki et al.,
2007). Further, at E9.5 there was a 4-fold increase in apoptosis in
the NC of the facial mesenchyme in Sp8 / mutants (Fig. 4A and
Fig. S4C and D). Similarly, at E10.5 apoptosis was signiﬁcantly
increased in both the MNP, LNP and OP (Fig. 4A and Fig. S4E and F).
We examined cell proliferation in the Sp8/ mutants by
immunostaining for phosphohistone H3. Interestingly, there was
a signiﬁcant reduction of cell proliferation in the NC at E9.5, but
not at E8.5 (Fig. 4B). At E10.5 there was a signiﬁcantly reduced cell
proliferation rate in the OP and LNP, but not the MNP. Together
these results suggest that a combination of increased apoptosis
and reduced cell division contribute to the dramatic craniofacial
phenotype of the Sp8 / mutants.
Reduced Fgf8 and Fgf17 expression in Sp8 / mutant signaling
centers
In situ hybridizations and Q-PCR were used to validate LCM/
microarray results. Wild type embryos expressed Fgf17 in the ANR
at E9.5 and along the midline and in the OP epithelium at E10.5
(Fig. 5D and E). Fgf17 was dramatically down-regulated in the Sp8
mutant ANR at E9.5 and in the midline and OP epithelium at E10.5(Fig. 5D and E). Q-PCR conﬁrmed signiﬁcant reduction of Fgf17
expression in E8.5 neural folds, E9.5 ANR, and E10.5 OP (Fig. 5G).
We also examined the expression pattern of Fgf8 in Sp8
mutants. As previously noted, Sp8 functions to maintain Fgf8
expression in the AER during limb bud development (Bell et al.,
2003). In addition, previous studies showed that SP8 can directly
bind and activate the Fgf8 promoter (Sahara et al., 2007), making it
an excellent candidate downstream target. In situ hybridizations
showed that Fgf8 expression was indeed down-regulated in the
Sp8 / mutant ANR at E9.5 (Fig. 5A). Erm and Sprouty are down-
stream targets of FGF8 signaling and both Erm and Sprouty
expression were also reduced in the mutant ANR (Fig. 5B and C).
Quantiﬁcation by Q-PCR conﬁrmed that Fgf8 transcripts were
signiﬁcantly down-regulated at E9.5, but not at E10.5 or E8.5,
consistent with in situ hybridization and microarray results
(Fig. 5G).
Due to the increased apoptosis in the Sp8 mutant NC and
neuroepithelium, we analyzed the expression of an ANR marker,
Dlx5, to determine whether the cells that make up the ANR are
present or absent in the mutant. In situ analysis of Dlx5 expression
showed E8.5 ANR speciﬁc expression, which was not lost in the
mutant (Fig. 5F). Therefore, the persistence of Dlx5 expression in
the E8.5 mutant ANR together with the reduced, but not absent
Fig. 5. Disrupted Fgf8, Fgf17 and Gli3 expression in Sp8/ embryos. (A–E) In situ hybridization revealed a down-regulation of Fgf17, Fgf8, and FGF8 downstream targets Erm
and Spry in E9.5 Sp8 mutant anterior neural ridge (arrows) (A–D). Fgf17 expression was also lost along the midline (arrowhead) and in the olfactory pit (arrows) at E10.5 (D).
(F) In situ hybridization showed no change in expression of the E8.5 anterior neural ridge marker Dlx5 in E8.5 Sp8 mutants (arrows). (G) Q-PCR analysis showed a down-
regulation of Fgf17 at E8.5, E9.5, and E10.5. Additionally at E9.5, Gli3, and Fgf8 expression levels were signiﬁcantly decreased in mutants. (H–J) Western blot analysis (H) and
relative levels (I) of GLI3 full length (transcriptional activator) and GLI3 repressor proteins showed a reduction in GLI3 full length and GLI3 repressor, although the change
was not statistically signiﬁcant. No signiﬁcant change in the ratio of GLI3 full length to repressor levels was detected (J). po0.05(n), po0.01(nn), po0.001 (nnn)
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up the ANR are not completely absent.
SHH and WNT signaling in Sp8 / mutants
We also investigated SHH signaling in the Sp8 mutants, which
showed a hypertelorism phenotype, with abnormally wide spa-
cing between the eyes. A loss of SHH signaling results in cyclopia,
while a gain of SHH signaling gives rise to hypertelorism (Belloni
et al., 1996; Hu and Helms, 1999; Hu and Marcucio, 2009; Lipinski
et al., 2010). In addition there is evidence that FGF and SHH
signaling can cross-regulate. In the chick system ectopic SHH in
the forebrain inhibits FGF8 expression (Hu and Marcucio, 2009),
while loss of Fgf8 expression in the ANR results in an expansion of
Shh expression (Creuzet et al., 2006). Further, the FGF8 down-
stream targets Pea3 and Erm have been shown to inhibit Shh
expression during limb development (Lettice et al., 2012; Mao
et al., 2009; Zhang et al., 2009). Therefore both the hypertelorism
phenotype and the reduced FGF expression in the Sp8 mutants
were consistent with possible elevated SHH signaling.
We examined multiple components of the SHH signaling pathway
using in situ hybridizations, Q-PCR, immunostain, transgenic reporter
mice, and western blot techniques. No signiﬁcant differences in SHH
expression were detected in Sp8 mutants at E8.5, E9.5 or E10.5 byimmunoﬂuorescence or using the Ptch-lacZ SHH reporter mouse (Fig.
S5B–E and data not shown). Q-PCR analysis of manually dissected
E10.5 combined MNP, LNP and OP revealed no change in the SHH
signaling components Shh, and Ptch1 (Fig. S5F). Likewise, Q-PCR
analysis of cranial neural folds at E8.5 showed no change in Shh,
Ptch1, Smo, Gli1, Gli2 or Gli3 (Fig. S5F). However, Gli3mRNA levels were
signiﬁcantly down-regulated in the E9.5 ANR and telencephalon
(Fig. 5G). GLI3 is a zinc ﬁnger transcription factor that mediates SHH
signal. Full length GLI3 functions as a transcriptional activator, while
the cleaved form is a transcriptional repressor (Dai et al., 1999; Liu
et al., 2005; Sasaki et al., 1999). To further deﬁne the perturbed Gli3
expressionwe performed western blot analysis. The results showed no
signiﬁcant change in the ratio of cleaved to full length forms suggest-
ing that GLI3 processing is not affected in the mutants (Fig. 5H–J). The
western blot results, although not as quantitative as Q-PCR, were
nevertheless consistent with reduced Gli3 expression. It is interesting
to note that Gli3 mutations in humans can cause Greig cephalopoly-
syndactyly syndrome (GCPS), associated with hypertelorism and
polydactyly (Vortkamp et al., 1991). GCPS is the result of reduced
Gli3 dosage and is found in heterozygotes with one wild type and one
null allele. Nevertheless, in mice even the homozygous loss of Gli3 is
not associated with hypertelorism (Veistinen et al., 2012).
In addition we used the Bat-gal reporter mice to analyze WNT
signaling in mutants and no change was detected (Fig. S5A).
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development in the Sp8 / face
Due to the hypertelorism phenotype and reduced Gli3 expres-
sionwe hypothesized that the elevated SHH signaling contributes to
the Sp8mutant craniofacial phenotype. To test this we ﬁrst reduced
SHH signaling by deleting one wild type Shh allele in Sp8 mutants.
The resulting Sp8 /;Shh+/ mice displayed a partially rescued
craniofacial phenotype (n¼4). The medial facial prominences
partially merged with the lateral and maxillary prominences to
form a recognizable snout by E18.5 (Fig. 6A–C). Sp8 /;Shh+/+
embryos had a signiﬁcant increase in the inner canthal distance
(ICD), a measure of hypertelorism, of 6.1 mm70.45 mm compared
to wild type ICD of 4.4 mm70.09 mm (p¼1.56E06). However,
the mutant hypertelorism was partially and signiﬁcantly rescued to
5.33 mm70.26 mm in Sp8 /;Shh+/ embryos (p¼9.3E02).
Despite the rescue of anterior structures, the more dorsal structures
of the skull and forehead were not rescued.
To further interrogate SHH signaling during craniofacial develop-
ment in Sp8mutants, we used a SHH signaling inhibitor, cyclopamine,
to reduce HH signaling in utero. Cyclopamine was initially adminis-
tered via intraperitoneal (IP) injection twice per day from E7.5–E10.0.
The result was one mutant showing a partial rescue with the facial
prominences being closer together than the unexposed mutants (Fig.
S6). Due to the low penetrance of the rescue via IP injection (1 rescue/
10 total exposed mutants), we used micro-osmotic pumps to provide
a more effective method of delivering cyclopamine. Micro-osmoticFig. 6. Reduction of SHH signaling partially rescued Sp8 craniofacial malformations. (A–
Shh+/ mutants displayed partial craniofacial rescue of anterior, but not dorsal, structure
exposure to cyclopamine. Wild type embryos appeared normal after exposure to 150 m
mutants (n¼41) displayed a partial rescue of facial midline (arrows), excencephaly, and
mutant phenotype (E).pumps implanted subcutaneously in pregnant mice were used to
release cyclopamine continuously for 24 h from E8.0 to E9.0. Mutants
exposed to cyclopamine displayed a robust, but partial, rescue of the
midline at E14.5 (n¼13, Fig. 6D–G). The rescue resulted in a much
more normal looking face (Fig. 6G versus 6E), with improvedmidfacial
development, although the MNPs remained distinct. The degree of
hypertelorism was measured by ICD in the cyclopamine exposed
litters. The ICD of cyclopamine exposed embryos that showed no
rescue (3.68 mm70.05 mm) was partially and signiﬁcantly rescued to
3.26 mm70.12 mm in the rescued mutants (p¼2.18E04). It is
important to note that the severe craniofacial phenotype of untreated
Sp8 mutants is near 100% penetrant. We have not observed any mice
resembling the partial rescue phenotypes in several hundred control
Sp8 / mutants. The cyclopamine doses used were relatively low (up
to 260mg/kg/day), and did not result in detectable phenotypes in any
WT littermates. There was variable response of the mutant embryos to
the cyclopamine, with many (n¼28) still showing the typical Sp8
mutant phenotype. We suspect this variability was the result of
varying cyclopamine concentrations along the length of the uterus.Discussion
In this report we show that mutation of the Sp8 zinc ﬁnger
transcription factor gene results in a striking craniofacial pheno-
type, with the multiple facial prominences severely reduced in size
and underdeveloped, even at E14.5. Interestingly, however, the Sp8C) SHH levels were reduced in Sp8 mutants by deleting one allele of Shh. Sp8 /;
s at E18.5 (n¼4, arrow in C). (D–G) SHH signaling was reduced through embryonic
g/kg cyclopamine (F). Approximately one-third (n¼13) of the cyclopamine treated
hypertelorism (G). Sp8 / mutants exposed to vehicle alone showed the standard
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mesoderm cells that together will construct the bone, muscle and
cartilage of the face. Instead, Sp8 showed elevated expression in
the neuroepithelium and epidermal ectoderm, which are known
to provide signaling centers that drive craniofacial development.
Cre-mediated compartment-speciﬁc deletion of Sp8 conﬁrmed
its function in signaling centers. Wnt1-Cre and Mesp1-Cre, used to
remove Sp8 function in the NC and paraxial mesoderm respec-
tively, gave no detectable craniofacial malformations. Of interest,
Wnt1-Cre also showed strong activity in the neuroepithelium of
the hindbrain, even at the earliest time point monitored, E8.5. The
wild type appearance of the Wnt1-Cre;Sp8ﬂox/ mouse indicated
that the hindbrain expression of Sp8 was not required for normal
craniofacial development.
Pax3-Cre was active in the neuroepithelium of the forebrain, as
well as the epidermal ectoderm and OP of the developing face. In
addition it was expressed in the NC cells, but the Wnt1-Cre results
showed that any low level Sp8 expression present in these cells
was not functionally signiﬁcant. The Pax3-Cre;Sp8ﬂox/ mice
showed the most severe craniofacial phenotypes, suggesting
important roles for Sp8 expression in the forebrain, OP and
epidermal ectoderm. The FoxG1-Cre results conﬁrmed this conclu-
sion, although the resulting phenotypes were less severe, perhaps
due to somewhat delayed and more mosaic expression compared
to Pax3-Cre.
Expression analysis, using LCM/microarray, in situ hybridiza-
tion, and Q-PCR showed reduced expression of Fgf8, Fgf17, Erm and
Spry in the Sp8 mutant E9.5 ANR. In addition, Fgf17 expression in
the E10.5 medial forebrain neuroepithelium and olfactory pit was
dramatically reduced in mutants. Both FGF8 and FGF17 have been
shown to drive proliferation and differentiation of neural cells (Xu
et al., 2000). The connection between FGF8 and cell proliferation is
particularly strong (Lee et al., 1997; MacArthur et al., 1995;
Shamim et al., 1999; Xu et al., 2000). Indeed, it has been shown
that FGF signaling is important at many stages of NC development,
including emigration from the neural tube (Martinez-Morales
et al., 2011), driving cartilage outgrowth (Abzhanov and Tabin,
2004), providing chemotactic attraction (Sato et al., 2011), survival
(Trumpp et al., 1999) and induction (Monsoro-Burq et al., 2003).
A recent report of mice with reduced FGF8 signaling exquisitely
deﬁned a number of craniofacial abnormalities approximating
those seen in Sp8 mutants (Grifﬁn et al., 2013). These included
reduced MNPs, midline clefts, shallow OP, and a dramatic mid-
facial cleft of the skull. The results of these previous studies are,
again, consistent with FGFs being key effectors of Sp8 during
craniofacial development. It therefore appears likely that the
reduced FGF signaling observed in the Sp8 mutants can account
for the majority of the observed craniofacial phenotype.
The connection between the Sp8 mutant phenotype and
perturbed SHH signaling is also of interest. The Sp8 mutants
showed a hypertelorism phenotype, which is also associated with
excessive SHH signaling. In addition it is known that reduced FGF
levels, as observed in the Sp8 mutants, can result in elevated SHH
(Lettice et al., 2012; Mao et al., 2009; Zhang et al., 2009). It
therefore seemed reasonable to hypothesize that increased SHH
signaling was in part responsible for the dramatic Sp8 mutant
craniofacial phenotype. Indeed, in utero treatment with the SHH
inhibitor cyclopamine did result in a striking partial rescue of the
mutant phenotype in a large fraction of mutants. Nevertheless, an
extensive analysis of the Sp8 mutants looking more directly for
perturbed SHH signaling levels revealed relatively little. The only
consistent change observed was a moderate reduction in Gli3
expression. In situ hybridizations, immunostains, the Ptch-lacZ
SHH reporter mouse and Q-PCR failed to ﬁnd signiﬁcant differ-
ences in a number of hedgehog signaling components, including
Smo, Indian Hedgehog, Gli1, Gli2 and Ptch, looking at multipledevelopmental time points. It is, however, very difﬁcult to prove a
negative result. In situ hybridization and immunostain methods
are not very quantitative. Q-PCR is quantitative but requires the
precise dissection of equivalent wild type and mutant tissues.
Further, the gross morphological differences of the Sp8 mutants
can make interpretations of results challenging, since exactly
corresponding structures are not always present. It is difﬁcult to
correlate expression patterns when the underlying embryologic
structures are distinct. It remains possible, therefore, that pertur-
bations in SHH signaling were missed.
The results, however, suggest an alternative possibility. Perhaps
the hypertelorism of the Sp8 mutants is not the result of increased
SHH signaling, but instead Sp8 and SHH are acting in independent
parallel pathways. For example, the Ephrin pathway (Babbs et al.,
2011), the PTPN11 gene (LEOPARD) (Limongelli et al., 2008), and
certain mutations of the TWIST1 gene (Saethre–Chotzen) (Firulli
et al., 2005) have also been associated with hypertelorism. That is,
the Sp8 mutation could cause hypertelorism through a non-SHH
related mechanism. In this case the reduction of SHH signaling
through cyclopamine treatment could partially rescue the Sp8 /
phenotype through its independent ability to regulate the hypo–
hyper-telorism axis.
It is also interesting to note that the frontonasal ectodermal
zone (FEZ), with both organizer and growth promoting properties,
is established at the SHH/FGF8 boundary (Hu et al., 2003). The FEZ
regulates both proximodistal growth and dorsoventral patterning
within the frontonasal prominence. The dramatically reduced Fgf8
expression in Sp8 mutants would be expected to perturb FEZ
formation and function, and could in part explain the disrupted
distal extension of snout structures.
A previous study used FoxG1-Cre to conditionally delete Fgf8 in
signaling centers during craniofacial development (Kawauchi
et al., 2005). The resulting phenotype resembled the Sp8 mutant
mice in several respects, with reduced MNP size, increased
apoptosis, and severe reduction or absence of olfactory structures.
It is also interesting to note that there was no detected change in
Shh expression. Another study of the telencephalic signaling
centers used a series of mutants to vary FGF8 doses, resulting in
increased apoptosis and decreased cell proliferation in the devel-
oping forebrain (Storm et al., 2006). Of particular interest, Sp8
expression in the ANR was dramatically reduced in Fgf8null/neo
mice, which have dramatically reduced Fgf8 expression. This
suggests the presence of a positive feedback loop between Sp8
and Fgf8, with Sp8 activating Fgf8 expression, which in turn
activates Sp8.
In this report we identify a crucial role for the Sp8 transcription
factor in the function of the ANR and OP signaling centers. The OP has
been shown to be capable of inducing bone and cartilage formation, as
well as providing a source of olfactory neurons and sensory epithelium
(Szabo-Rogers et al., 2009). Further, many key OP functions are
mediated by FGF signaling (Szabo-Rogers et al., 2008). Appropriate
levels of the growth factorsWNT, BMP and FGF signaling are necessary
for olfactory placode induction (Ahrens and Schlosser, 2005;
Brugmann et al., 2004; Litsiou et al., 2005). In addition the transcrip-
tion factors Pax6 (Grindley et al., 1995), Dlx5 (Bhattacharyya and
Bronner-Fraser, 2008), Six1, Six4 (Chen et al., 2009), Sox2 and Pou2f1
(Donner et al., 2007) have all been shown to play critical roles in the
formation of the OP. In contrast, we observed that Sp8 is not needed to
establish the OP, but rather is required for proper FGF signaling
function. This is quite similar to what we previously observed in the
AER signaling center of the developing limb, where Sp8 is not essential
for its establishment, but is needed for AER maturation and FGF
signaling function (Bell et al., 2003).
Relatively little is known of the genetic regulatory program that
produces the ANR. The ANR signaling center plays a key role in both
prosencephalon (Paek et al., 2009) and craniofacial development. The
A.D. Kasberg et al. / Developmental Biology 381 (2013) 312–323322ANR is generally described as the rostral most part of the forebrain,
deﬁned by FGF8 expression as embryos reach ﬁve somites
(Shimamura and Rubenstein, 1997). Many of the same genes are
expressed in the OP and ANR, including Fgf8, Dlx5, Pax6 and Six3.
In this report we show that the FGF signaling function of the ANR is
disrupted in Sp8 mutants.
In summary, we have shown that Sp8 is required for Fgf8 and
Fgf17 expression in important craniofacial development signaling
centers. Increased apoptosis coupled with reduced cell prolifera-
tion of NC cells likely account for the reduced facial prominences
in Sp8 mutants. In addition we showed that genetic and pharma-
ceutical reduction of SHH signaling in mutants resulted in a
conspicuous, but partial, craniofacial rescue. There is a striking
commonality of Sp8 function in the developing limbs and face.
In each case Sp8 is required for FGF production in key signaling
centers that direct development.Acknowledgments
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